References
- Day R. O., Furst D. E., Dromgoole S. H., Kamm B., Roe R., Paulus H. E. Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clin Pharmacol Ther 1982; 31(6)733
- Gamst O. N., Haga A. K., Holler T., Farup A. H. Absorption of naproxen from enteric coated tablets. Nor Pharm Acta 1984; 46: 1
- Katona G., Balderama F., Ortega E. Single nightly dose naproxen therapy: a double blind trial. Curr Ther Res 1979; 25(4)493
- Luftschein S., Bienenstock H., Varady J. C., Stitt F. W. Increasing dose of naproxen in rheumatoid arthritis: use with and without corticosteroids. J Rheumatol 1979; 6(4)397
- Laine V., Strandman D., Tikkanen R. Tarmløslig acetylsalicylsyra och plasmats salicylatkon-centration pa morgonen. Läkartidn. 65 1968; 39: 3832
- Tronstad R. I., Aadland E., Holler T., Olaussen B. O. Effect of enteric coated and plain naproxen tablets on the gastric mucosa in healthy subjects. Scand J Gastroenterol 1985; 20: 239